Integrated BioPharma INBP Stock
Integrated BioPharma Price Chart
Integrated BioPharma INBP Financial and Trading Overview
| Integrated BioPharma stock price | 0.19 USD |
| Previous Close | 0.18 USD |
| Open | 0.18 USD |
| Bid | 0.17 USD x 814000 |
| Ask | 0.2 USD x 1646200 |
| Day's Range | 0.18 - 0.18 USD |
| 52 Week Range | 0.17 - 0.42 USD |
| Volume | 8K USD |
| Avg. Volume | 7.36K USD |
| Market Cap | 5.9M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.05 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
INBP Valuation Measures
| Enterprise Value | 3.41M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.12230474 |
| Price/Book (mrq) | 0.31096563 |
| Enterprise Value/Revenue | 0.071 |
| Enterprise Value/EBITDA | -3.577 |
Trading Information
Integrated BioPharma Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -32.14% |
| S&P500 52-Week Change | 27.29% |
| 52 Week High | 0.42 USD |
| 52 Week Low | 0.17 USD |
| 50-Day Moving Average | 0.25 USD |
| 200-Day Moving Average | 0.29 USD |
INBP Share Statistics
| Avg. Volume (3 month) | 7.36K USD |
| Avg. Daily Volume (10-Days) | 10.44K USD |
| Shares Outstanding | 31.06M |
| Float | 7.38M |
| Short Ratio | 0 |
| % Held by Insiders | 68.42% |
| % Held by Institutions | 0.064% |
| Shares Short | 10.6K |
| Short % of Float | N/A |
| Short % of Shares Outstanding | 0% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | June 30, 2026 |
Profitability
| Profit Margin | -3.42% |
| Operating Margin (ttm) | -10.73% |
| Gross Margin | 4.64% |
| EBITDA Margin | -1.97% |
Management Effectiveness
| Return on Assets (ttm) | -2.97% |
| Return on Equity (ttm) | -8.40% |
Income Statement
| Revenue (ttm) | 48.25M USD |
| Revenue Per Share (ttm) | 1.56 USD |
| Quarterly Revenue Growth (yoy) | -27.50% |
| Gross Profit (ttm) | 2.24M USD |
| EBITDA | -953000 USD |
| Net Income Avi to Common (ttm) | -1654000 USD |
| Diluted EPS (ttm) | -0.05 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 5.83M USD |
| Total Cash Per Share (mrq) | 0.19 USD |
| Total Debt (mrq) | 3.35M USD |
| Total Debt/Equity (mrq) | 17.63 USD |
| Current Ratio (mrq) | 3.252 |
| Book Value Per Share (mrq) | 0.611 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 3.03M USD |
| Levered Free Cash Flow (ttm) | 4.17M USD |
Profile of Integrated BioPharma
| Country | United States |
| State | NJ |
| City | Hillside |
| Address | Building 15 |
| ZIP | 07205 |
| Phone | (888) 319-6962 |
| Website | https://ir.ibiopharma.com |
| Industry | Packaged Foods |
| Sector(s) | Consumer Defensive |
| Full Time Employees | 153 |
Integrated BioPharma, Inc., together with its subsidiaries, engages in the manufacturing, distributing, marketing and sale of vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. The company operates through two segments, Contract Manufacturing and Other Business Lines. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Other Nutraceutical Businesses segment provides warehousing and fulfilment services; and distributes raw materials. The company was formerly known as Integrated Health Technologies, Inc. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey.
Q&A For Integrated BioPharma Stock
What is a current INBP stock price?
Integrated BioPharma INBP stock price today per share is 0.19 USD.
How to purchase Integrated BioPharma stock?
You can buy INBP shares on the OTC Markets OTCQX exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Integrated BioPharma?
The stock symbol or ticker of Integrated BioPharma is INBP.
Which industry does the Integrated BioPharma company belong to?
The Integrated BioPharma industry is Packaged Foods.
How many shares does Integrated BioPharma have in circulation?
The max supply of Integrated BioPharma shares is 31.06M.
What is Integrated BioPharma Price to Earnings Ratio (PE Ratio)?
Integrated BioPharma PE Ratio is now.
What was Integrated BioPharma earnings per share over the trailing 12 months (TTM)?
Integrated BioPharma EPS is -0.05 USD over the trailing 12 months.
Which sector does the Integrated BioPharma company belong to?
The Integrated BioPharma sector is Consumer Defensive.